Haemopoietic stem-cell transplantation: recent progress and future promise

Area of Science:

• Hematology
• Oncology
• Immunology

Background:

• Haemopoietic stem cell transplantation (HSCT) is crucial for treating hematological malignancies.
• Advances in stem cell biology are transforming autologous and allogeneic HSCT practices.

Purpose of the Study:

• To review recent developments in HSCT, focusing on stem cell sources, disease relapse, and graft-versus-leukaemia effects.
• To highlight strategies for improving HSCT efficacy and safety.

Main Methods:

• Review of current literature on stem cell mobilization, conditioning regimens, and graft-versus-leukaemia strategies.
• Analysis of the shift from bone marrow to peripheral blood stem cells.

Main Results:

• Granulocyte colony-stimulating factor (G-CSF) enables mobilization of haemopoietic progenitors, making peripheral blood the preferred stem cell source.
• Disease relapse is the primary cause of treatment failure in autografting, driving research into novel conditioning and tumor purging.
• The graft-versus-leukaemia effect is increasingly recognized, leading to strategies that enhance immune-mediated anti-tumor activity.

Conclusions:

• Peripheral blood stem cell transplantation has reduced autograft morbidity, shifting focus to relapse prevention.
• Optimizing the graft-versus-leukaemia effect and developing less toxic conditioning regimens are key for expanding allogeneic HSCT benefits to more patients.